Chong-Xian Pan

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 7

Top Venues

Cancer cytopathology

Cancer immunology, immunotherapy : CII

Journal of experimental & clinical cancer research : CR

Journal of hematology & oncology

Harvard Medical School

University of California Davis School of Medicine (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Harvard Medical School

United States

Faculty of Medicine

Education History

University of California Davis School of Medicine

United States

MSC

Publications

Mohamed A Abd El-Salam, Maria J Troulis, Chong-Xian Pan, Rema A Rao
Unlocking the potential of organoids in cancer treatment and translational research: An application of cytologic techniques. Cancer cytopathology (2023)
Mohamed A Abd El-Salam, Claire E P Smith, Chong-Xian Pan
Insights on recent innovations in bladder cancer immunotherapy. Cancer cytopathology 130 (9) (2022)
Kevin Pan, Hizra Farrukh, Veera Chandra Sekhar Reddy Chittepu, Huihong Xu, Chong-Xian Pan, Zheng Zhu
CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy. Journal of experimental & clinical cancer research : CR 41 (1) (2022)
Shaoming Zhu, A-Hong Ma, Zheng Zhu, Elio Adib, Ting Rao, Na Li, Kaiyuan Ni, Veera Chandra Sekhar Reddy Chittepu, Rao Prabhala, Juan Garisto Risco, David Kwiatkowski, Kent Mouw, Guru P Sonpavde, Fan Cheng, Chong-Xian Pan
Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancer. Journal for immunotherapy of cancer 9 (11) (2022)
Zheng Zhu, Ai-Hong Ma, Hongyong Zhang, Tzu-Yin Lin, Xiangdong Xue, Hizra Farrukh, Shaoming Zhu, Wei Shi, Ruan Yuan, Zhixiu Cao, Veera Chandra Sekhar Reddy Chittepu, Rao Prabhala, Yuanpei Li, Kit S Lam, Chong-Xian Pan
Phototherapy with Cancer-Specific Nanoporphyrin Potentiates Immunotherapy in Bladder Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (21) (2022)
Shaoming Zhu, Tian Zhang, Lei Zheng, Hongtao Liu, Wenru Song, Delong Liu, Zihai Li, Chong-Xian Pan
Combination strategies to maximize the benefits of cancer immunotherapy. Journal of hematology & oncology 14 (1) (2021)
Qilai Long, Ai-Hong Ma, Hongyong Zhang, Zhixiu Cao, Roger Xia, Tzu-Yin Lin, Guru P Sonpavde, Ralph de Vere White, Jianming Guo, Chong-Xian Pan
Combination of cyclin-dependent kinase and immune checkpoint inhibitors for the treatment of bladder cancer. Cancer immunology, immunotherapy : CII 69 (11) (2020)

Chong-Xian Pan.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Chong-Xian Pan